Matthias W.
- Country
- Germany
- Department
- Schwerpunkt Endokrinologie und Stoffwechselerkrankungen; Endokrinologische Ambulanz
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Evaluation of Cabozantinib and Avelumab Combination Therapy in Advanced Neuroendocrine Neoplasias G3 Refractory to Standard Chemotherapy
- Evaluation of Safety and Tolerability of VRDN-003 in Patients with Thyroid Eye Disease: A Randomized, Double-Masked, Controlled Study
Data & Insights
Has run more than one trial at 49 of 424 partner sites.
Specializations
Neuroendocrine Oncology
This investigator specializes in treating advanced neuroendocrine neoplasias, with particular focus on high-grade (G3) tumors. Their research interest centers on developing innovative therapeutic approaches for patients who have not responded to conventional treatment methods.
- Advanced NEN G3 Management
- Treatment-Resistant Neuroendocrine Tumors
- Progressive Disease Control
The investigator's work excludes small cell lung cancer and Merkel cell carcinomas, focusing specifically on other forms of neuroendocrine neoplasias.
Immunotherapy Research
The investigator's expertise extends to combination immunotherapy approaches, exploring novel treatment strategies that pair different therapeutic agents. Their work involves evaluating immune checkpoint inhibitors in combination with targeted therapies.
- Combination Treatment Strategies
- Immune System Modulation
- Response Assessment Methods
Their research emphasizes measuring treatment efficacy through specialized response criteria for immunotherapy treatments.
Therapeutic Innovation
The investigator focuses on developing alternative treatment pathways for patients who have exhausted standard chemotherapy options. Their work involves evaluating novel therapeutic combinations to improve disease control rates.
- Treatment-Resistant Disease
- Advanced Stage Cancer Therapy
- Long-term Disease Management
Their approach includes regular monitoring of treatment responses through systematic assessment intervals.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.